Fluorescence anisotropy imaging in drug discovery
Advanced Drug Delivery Reviews
Abstract
"Non-invasive measurement of drug-target engagement can provide critical insights in the molecular pharmacology of small molecule drugs. Fluorescence polarization/fluorescence anisotropy measurements are commonly employed in protein/cell screening assays. However, the expansion of such measurements to the in vivo setting has proven difficult until recently. With the advent of high-resolution fluorescence anisotropy microscopy it is now possible to perform kinetic measurements of intracellular drug distribution and target engagement in commonly used mouse models. In this review we discuss the background, current advances and future perspectives in intravital fluorescence anisotropy measurements to derive pharmacokinetic and pharmacodynamic measurements in single cells and whole organs. (C) 2018 Elsevier B.V. All rights reserved."
Full citation
For attribution in academic contexts, please cite this work as:
Vinegoni#, C., Feruglio, P. F., Gryczynski, I., Mazitschek, R., & Weissleder, R. (2019). Fluorescence anisotropy imaging in drug discovery. Advanced Drug Delivery Reviews, 151, 262–288. https://doi.org/10.1016/j.addr.2018.01.019 |

Vinegoni#, C., Feruglio, P. F., Gryczynski, I., Mazitschek, R., & Weissleder, R. (2019). Fluorescence anisotropy imaging in drug discovery. Advanced Drug Delivery Reviews, 151, 262–288. https://doi.org/10.1016/j.addr.2018.01.019